The new World Health Organization guideline recognizes obesity as a chronic disease that can be treated with drug therapy as ...

India’s obesity crisis is colliding with a transformative moment in treatment, as GLP-1 therapies and a key court ruling on ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.

The WHO’s announcement came hours after Australia released a safety alert over the potential risk of suicidal thoughts and ...

In Naples, on Wednesday, December 3rd, the IRCCS Fondazione Pascale hosted the congress 'Cancer and Obesity: A Strong Often ...

HealthDay News — Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adults with obesity, according to a special communication from the ...

When Marilou Paladin, 42, of Quezon City, began her weight-management journey, her biggest hurdle wasn't portion control. It ...

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, ...

Obesity brings with it a host of other health-related issues, such as diabetes, which affects all organs, including the eyes.

Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for ...

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...